Difference between revisions of "IL21R-AS1"
Line 3: | Line 3: | ||
IL21R-AS1 (IL21R antisense RNA 1) | IL21R-AS1 (IL21R antisense RNA 1) | ||
[[File:Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients and control subjects.png|right|thumb|200px|'''Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15).''']] | [[File:Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients and control subjects.png|right|thumb|200px|'''Expression levels of CoroMarker,IL21R-AS1,BAT5,AC107016.1,and RP11-203B9.4 were quantified by qPCR in the PBMCs of CAD patients (n = 15) and control subjects (n = 15).''']] | ||
− | [[File:Expression levels of CoroMarker, IL21R-AS1, and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20). (A–C) Expression levels of lncRNAs: CoroMarker (A), IL21R-AS1 (B), and BAT5 (C). *P< 0.05 vs. control. (D–F) ROC curve analyses of CoroMarker, IL21R-AS1, and BAT5 for the diagnosis of CAD. AUROC indicates area under the ROC curve | + | [[File:Expression levels of CoroMarker,IL21R-AS1,and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20). (A–C) Expression levels of lncRNAs: CoroMarker(A),IL21R-AS1(B),and BAT5 (C).*P< 0.05 vs.control.(D–F) ROC curve analyses of CoroMarker,IL21R-AS1,and BAT5 for the diagnosis of CAD.AUROC indicates area under the ROC curve.png|right|thumb|200px|'''Expression levels of CoroMarker, IL21R-AS1, and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20).(A–C) Expression levels of lncRNAs:CoroMarker(A),IL21R-AS1(B),and BAT5(C).*P< 0.05 vs.control.(D–F) ROC curve analyses of CoroMarker,IL21R-AS1,and BAT5 for the diagnosis of CAD.AUROC indicates area under the ROC curve.''']] |
===Chromosome=== | ===Chromosome=== | ||
16p12.1 | 16p12.1 |
Revision as of 08:04, 15 October 2017
Contents
Annotated Information
Approved Symbol
IL21R-AS1 (IL21R antisense RNA 1)
[[File:Expression levels of CoroMarker,IL21R-AS1,and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20). (A–C) Expression levels of lncRNAs: CoroMarker(A),IL21R-AS1(B),and BAT5 (C).*P< 0.05 vs.control.(D–F) ROC curve analyses of CoroMarker,IL21R-AS1,and BAT5 for the diagnosis of CAD.AUROC indicates area under the ROC curve.png|right|thumb|200px|Expression levels of CoroMarker, IL21R-AS1, and BAT5 were quantified by qPCR in the PBMCs of CAD patients (n = 20) and control subjects (n = 20).(A–C) Expression levels of lncRNAs:CoroMarker(A),IL21R-AS1(B),and BAT5(C).*P< 0.05 vs.control.(D–F) ROC curve analyses of CoroMarker,IL21R-AS1,and BAT5 for the diagnosis of CAD.AUROC indicates area under the ROC curve.]]
Chromosome
16p12.1
RefSeq ID
NR_037158
Expression
qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.[1]
Disease
coronary artery disease. [1]
Labs working on this lncRNA
- Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.
- Chongqing Institute of Cardiology, Chongqing, P.R. China.